Importance of 503A Compounding and Clinical Oversight The 503A designation is critical for injectable GHK-Cu, particularly in a clinical context
This hormone does 3 important things: Tells your pancreas Food has arrived, release insulin now Tells your liver Stop releasing extra sugar Tells your brain You are full, stop eating In Type 2 diabetes, this GLP-1 response becomes weak and sluggish
USA 100 , 61046108 (2003)
Theyre all in a class of drugs called GLP-1 agonists and mimic the effects of a hormone the body releases when people eat food
"Because in obese populations, as much as 75% of the patients would have excess fat in the liver, but now we could have a treatment that allows you to wipe out the liver fat in patients with early-stage liver disease," he said
It has been show diminished GSH/GSSG ratios in the kidneys of 8-month-old versus 4-month-old (NZB x NZW) F1 mice, and treatment with N-acetylcysteine (NAC), a precursor of GSH and stimulator of its de novo biosynthesis, prevented decline of GSH/GSSG ratios, reduced autoantibody production and development of glomerulonephritis and prolonged survival of (NZB x NZW) F1 mice [134]
